Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of clinically
aggressive diseases associated with poor prognosis. Except for ALK+ anaplastic large-cell …

Due to heterogeneous morphological and immunophenotypic features, approximately 50%
of peripheral T-cell lymphomas are unclassifiable and categorized as peripheral T-cell …

Peripheral T-cell lymphoma (PTCL) is a group of complex clinicopathological entities, often
associated with an aggressive clinical course. Angioimmunoblastic T-cell lymphoma (AITL) …

Peripheral T-cell lymphoma (PTCL) is an uncommon group of lymphoma covering a diverse
spectrum of entities. Little was known regarding the molecular and genomic landscapes of …

Objective To explore the correlation of mutation landscape with clinical outcomes in patients
with peripheral T-cell lymphoma (PTCL). Methods We retrospectively analyzed the …

Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies
characterized by a usually aggressive clinical course. The current World Health …

Peripheral T cell lymphomas (PTCLs) are heterogeneous neoplasms and represent about
12% of all lymphoid malignancies. They are often regarded as “orphan diseases,” a …

Peripheral T-cell lymphomas (PTCLs) are uniquely vulnerable to epigenetic modifiers. We
demonstrated in vitro synergism between histone deacetylase inhibitors and DNA …

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are …

Purpose of review Peripheral T cell lymphomas (PTCLs) are markedly heterogeneous at the
clinical, pathological, and molecular levels. This review will discuss genetic findings in PTCL …